Your browser doesn't support javascript.
loading
Risk of cardiovascular disease morbidity and mortality in frail and pre-frail older adults: Results from a meta-analysis and exploratory meta-regression analysis.
Veronese, Nicola; Cereda, Emanuele; Stubbs, Brendon; Solmi, Marco; Luchini, Claudio; Manzato, Enzo; Sergi, Giuseppe; Manu, Peter; Harris, Tamara; Fontana, Luigi; Strandberg, Timo; Amieva, Helene; Dumurgier, Julien; Elbaz, Alexis; Tzourio, Christophe; Eicholzer, Monika; Rohrmann, Sabine; Moretti, Claudio; D'Ascenzo, Fabrizio; Quadri, Giorgio; Polidoro, Alessandro; Lourenço, Roberto Alves; Moreira, Virgilio Garcia; Sanchis, Juan; Scotti, Valeria; Maggi, Stefania; Correll, Christoph U.
Afiliação
  • Veronese N; Department of Medicine (DIMED), Geriatrics Division, University of Padova, Italy; Institute for Clinical Research and Education in Medicine (IREM), Padova, Italy; National Research Council, Neuroscience Institute-Aging Branch, Padova, Italy. Electronic address: ilmannato@gmail.com.
  • Cereda E; Nutrition and Dietetics Service, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Stubbs B; Physiotherapy Department, South London and Maudsley NHS FoundationTrust, Denmark Hill, London SE5 8AZ, United Kingdom; Health Service and Population Research Department, Institute of Psychiatry, King's College London, De Crespigny Park, London SE5 8AF, United Kingdom; Health, Social Care and Educati
  • Solmi M; Institute for Clinical Research and Education in Medicine (IREM), Padova, Italy; Department of Neurosciences, University of Padova, Padova, Italy; National Health Care System, Monselice, Padova Local Unit ULSS 17, Italy.
  • Luchini C; Department of Pathology and Diagnostics, University and Hospital Trust of Verona, Verona, Italy; Surgical Pathology Unit, Santa Chiara Hospital, Trento, Italy.
  • Manzato E; Department of Medicine (DIMED), Geriatrics Division, University of Padova, Italy; National Research Council, Neuroscience Institute-Aging Branch, Padova, Italy.
  • Sergi G; Department of Medicine (DIMED), Geriatrics Division, University of Padova, Italy.
  • Manu P; South Oaks Hospital, Northwell Health,400 Sunsrise Highway, Amityville, NY 11701, USA.
  • Harris T; Laboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
  • Fontana L; Division of Geriatrics and Nutritional Sciences and Center for Human Nutrition, Washington University School of Medicine, St. Louis, MO, USA; Department of Clinical and Experimental Sciences, Brescia University, Brescia, Italy; CEINGE Biotecnologie Avanzate, Napoli, Italy.
  • Strandberg T; University of Helsinki and Helsinki University Hospital, Helsinki, Finland; University of Oulu,Center for Life Course Health Research, Oulu, Finland.
  • Amieva H; Centre de Recherche Inserm, Bordeaux, France; University Victor Segalen Bordeaux 2, Bordeaux, France.
  • Dumurgier J; CMRR Paris Nord AP-HP, Groupe Hospitalier Lariboisière Fernand-Widal Saint-Louis, INSERM, U942, Université Paris Diderot, Sorbonne Paris Cité, UMRS 942, Paris, France.
  • Elbaz A; CESP, Univ. Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Tzourio C; University of Bordeaux, Neuroepidemiology, UMR897, Bordeaux, France.
  • Eicholzer M; University of Zurich, Epidemiology, Biostatistics and Prevention Institute, Division of Chronic Disease Epidemiology, Hirschengraben 84, CH-8001 Zurich, Switzerland.
  • Rohrmann S; University of Zurich, Epidemiology, Biostatistics and Prevention Institute, Division of Chronic Disease Epidemiology, Hirschengraben 84, CH-8001 Zurich, Switzerland.
  • Moretti C; Division of Cardiology, Department of Science, Città della Salute e della Scienza, Turin, Italy.
  • D'Ascenzo F; Division of Cardiology, Department of Science, Città della Salute e della Scienza, Turin, Italy.
  • Quadri G; Division of Cardiology, Department of Science, Città della Salute e della Scienza, Turin, Italy.
  • Polidoro A; Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
  • Lourenço RA; Department of Internal Medicine, Faculty of Medical Sciences, State University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Moreira VG; Department of Internal Medicine, Faculty of Medical Sciences, State University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Sanchis J; Department of Cardiology, Hospital Clínico Universitario, School of Medicine, University of Valencia, Valencia, (CIBER-CV), Spain.
  • Scotti V; Clinical Epidemiology and Biometric Unit, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.
  • Maggi S; National Research Council, Neuroscience Institute-Aging Branch, Padova, Italy.
  • Correll CU; The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, New York, USA; Hofstra Northwell School of Medicine, Hempstead, NY, USA; The Feinstein Institute for Medical Research, Manhasset, NY, USA; Albert Einstein College of Medicine, Bronx, NY, USA.
Ageing Res Rev ; 35: 63-73, 2017 May.
Article em En | MEDLINE | ID: mdl-28143778
ABSTRACT
Frailty is common and associated with poorer outcomes in the elderly, but its role as potential cardiovascular disease (CVD) risk factor requires clarification. We thus aimed to meta-analytically evaluate the evidence of frailty and pre-frailty as risk factors for CVD. Two reviewers selected all studies comparing data about CVD prevalence or incidence rates between frail/pre-frail vs. robust. The association between frailty status and CVD in cross-sectional studies was explored by calculating and pooling crude and adjusted odds ratios (ORs) ±95% confidence intervals (CIs); the data from longitudinal studies were pooled using the adjusted hazard ratios (HRs). Eighteen cohorts with a total of 31,343 participants were meta-analyzed. Using estimates from 10 cross-sectional cohorts, both frailty and pre-frailty were associated with higher odds of CVD than robust participants. Longitudinal data were obtained from 6 prospective cohort studies. After a median follow-up of 4.4 years, we identified an increased risk for faster onset of any-type CVD in the frail (HR=1.70 [95%CI, 1.18-2.45]; I2=66%) and pre-frail (HR=1.23 [95%CI, 1.07-1.36]; I2=67%) vs. robust groups. Similar results were apparent for time to CVD mortality in the frail and pre-frail groups. In conclusion, frailty and pre-frailty constitute addressable and independent risk factors for CVD in older adults.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Aged / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Aged / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article